Blood Perfusion and Cellular Microstructural Changes Associated With Iron Deposition in Multiple Sclerosis Lesions

作者: Huaqiang Sheng , Bin Zhao , Yulin Ge

DOI: 10.3389/FNEUR.2019.00747

关键词:

摘要: Background and Purpose: Susceptibility-weighted imaging (SWI) has emerged as a useful clinical tool in many neurological diseases including multiple sclerosis (MS). This study aims to investigate the relationship between SWI signal changes due iron deposition MS lesions tissue blood perfusion microstructural abnormalities better understand their underlying histopathologies. Methods: Forty-six patients with relapsing remitting were recruited for this study. Conventional FLAIR, pre- post-contrast T1-weighted imaging, SWI, diffusion tensor (DTI), dynamic susceptibility contrast (DSC) MRI performed these at 3T. The was processed using both magnitude phase information one slice minimal intensity projection (mIP) multiplication factor of 4. classified into 3 types based on lesional appearance mIP relative perilesional normal appearing white matter (peri-NAWM): Type-1: hypointense, Type-2: isointense, Type-3: hyperintense lesions. DTI DSC data offline generate DTI-derived mean diffusivity (MD) fractional anisotropy (FA) maps, well DSC-derived cerebral flow (CBF) volume (CBV) maps. Comparisons measurements peri-NAWM, different lesions, performed. Results: A total 137 identified FLAIR that include 40 Type-1, 46 Type-2, 51 Type-3 according peri-NAWM. All lesion showed significant higher MD lower FA compared peri-NAWM (P < 0.0001). Compared Type-1 (likely represent deposition), Type-2 had significantly 0.001) 0.05), while Type 0.05). 0.0001) marginally Conclusion: differences metrics associated appear may help identify destructive pathways myelin axons evolution related inflammatory activities.

参考文章(41)
J. C. E. Kaufmann, J. C. Walton, Iron deposits and multiple sclerosis. Archives of Pathology & Laboratory Medicine. ,vol. 108, pp. 755- 756 ,(1984)
Simon Hametner, Isabella Wimmer, Lukas Haider, Sabine Pfeifenbring, Wolfgang Brück, Hans Lassmann, Iron and neurodegeneration in the multiple sclerosis brain Annals of Neurology. ,vol. 74, pp. 848- 861 ,(2013) , 10.1002/ANA.23974
S. M. LeVine, W. B. Macklin, Iron-enriched oligodendrocytes: a reexamination of their spatial distribution. Journal of Neuroscience Research. ,vol. 26, pp. 508- 512 ,(1990) , 10.1002/JNR.490260415
Veela Mehta, Wei Pei, Grant Yang, Suyang Li, Eashwar Swamy, Aaron Boster, Petra Schmalbrock, David Pitt, Iron Is a Sensitive Biomarker for Inflammation in Multiple Sclerosis Lesions PLoS ONE. ,vol. 8, pp. e57573- ,(2013) , 10.1371/JOURNAL.PONE.0057573
Michael Khalil, Charlotte Teunissen, Christian Langkammer, Iron and Neurodegeneration in Multiple Sclerosis Multiple Sclerosis International. ,vol. 2011, pp. 606807- 606807 ,(2011) , 10.1155/2011/606807
Don H Mahad, Bruce D Trapp, Hans Lassmann, Pathological mechanisms in progressive multiple sclerosis Lancet Neurology. ,vol. 14, pp. 183- 193 ,(2015) , 10.1016/S1474-4422(14)70256-X
Diego Di Lorenzo, Giorgio Biasiotto, Isabella Zanella, Source of iron overload in multiple sclerosis. Cellular and Molecular Life Sciences. ,vol. 71, pp. 3187- 3189 ,(2014) , 10.1007/S00018-014-1641-0
Reta Haselhorst, Ludwig Kappos, Deniz Bilecen, Klaus Scheffler, David M�ri, Ernst W. Rad�, Joachim Seelig, Dynamic susceptibility contrast MR imaging of plaque development in multiple sclerosis: application of an extended blood-brain barrier leakage correction. Journal of Magnetic Resonance Imaging. ,vol. 11, pp. 495- 505 ,(2000) , 10.1002/(SICI)1522-2586(200005)11:5<495::AID-JMRI5>3.0.CO;2-S
X. Zhang, N. Surguladze, B. Slagle-Webb, A. Cozzi, J. R. Connor, Cellular iron status influences the functional relationship between microglia and oligodendrocytes. Glia. ,vol. 54, pp. 795- 804 ,(2006) , 10.1002/GLIA.20416
Maxim Bester, Nils Daniel Forkert, Jan Patrick Stellmann, Klarissa Stürner, Lilian Aly, Anna Drabik, Kim Lea Young, Christoph Heesen, Jens Fiehler, Susanne Siemonsen, Correction: Increased Perfusion in Normal Appearing White Matter in High Inflammatory Multiple Sclerosis Patients PLOS ONE. ,vol. 10, pp. e0142464- ,(2015) , 10.1371/JOURNAL.PONE.0142464